Michael Kaschke Insider Profile
4 Followers
Michael Kaschke, Director at Carl Zeiss Meditec, holds ― shares in Ottobock SE & Co. KGaA (Ticker: OBCKF), holds ― shares in Carl Zeiss Meditec (Ticker: GB:0DHC). Most recently, Michael Kaschke Bought ― shares of Ottobock SE & Co. KGaA on Mar 27, 2026 for an estimated value of $54.25K.
Profitable Transactions
1 out of 5 Profitable Transactions
Average Return
-3.50%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Michael Kaschke does not currently own shares as a corporate insider.
A breakdown of Michael Kaschke's holdings
Insider Roles
Roles that Michael Kaschke holds in companies
Most Profitable Insider Trade
The most profitable trade made by Michael Kaschke
Michael Kaschke's Trading History
Carl Zeiss Meditec
Jan 22, 2013
Director
Informative Sell
94.06K
―
Ottobock SE & Co. KGaA
Mar 27, 2026
Director
Informative Buy
54.25K
―
List of latest transactions for each holding click on a transaction to see Michael Kaschke's performance on stock
You May Also Like
Michael Kaschke insider profile FAQ
What is the percentage of profitable transactions made by Michael Kaschke?
The percentage of profitable transactions made by Michael Kaschke is 20%.
What is the average return per transaction made by Michael Kaschke?
The average return per transaction made by Michael Kaschke is -3.50%.
What stocks does Michael Kaschke hold?
Michael Kaschke holds: GB:0DHC, OBCKF stocks.
What was Michael Kaschke’s latest transaction?
Michael Kaschke latest transaction was an Informative Buy of $54.25K.
What was Michael Kaschke's most profitable transaction?
Michael Kaschke’s most profitable transaction was an Informative Buy of GB:0DHC stock on January 29, 2009. The return on the trade was 24.00%.
What is Michael Kaschke's role in Carl Zeiss Meditec?
Michael Kaschke's role in Carl Zeiss Meditec is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.